Gilead Shares Are Trading Lower After the Company's Phase 3 TROPiCS-04 Study Missed Its Primary Endpoint of Overall Survival.
Gilead Shares Are Trading Lower After the Company's Phase 3 TROPiCS-04 Study Missed Its Primary Endpoint of Overall Survival.
吉利德的第三階段Tropics-04研究未達到其總體存活率的主要終點後，該公司的股價走低。
Gilead Shares Are Trading Lower After the Company's Phase 3 TROPiCS-04 Study Missed Its Primary Endpoint of Overall Survival.
吉利德的第三階段Tropics-04研究未達到其總體存活率的主要終點後，該公司的股價走低。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。